Potent and selective LXR inverse agonist (IC50 values are 43 and 214 nM for LXRβ and LXRα, respectively). Selectively inhibits liver LXR over peripheral LXR. Exhibits selectivity for LXR over a panel of 20 other nuclear receptors, including FXR. Reduces hepatic steatosis in obese mice.
|Storage||Store at +4°C|
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
|Solvent||Max Conc. mg/mL||Max Conc. mM|
Preparing Stock Solutions
The following data is based on the product molecular weight 595.73. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|1 mM||1.68 mL||8.39 mL||16.79 mL|
|5 mM||0.34 mL||1.68 mL||3.36 mL|
|10 mM||0.17 mL||0.84 mL||1.68 mL|
|50 mM||0.03 mL||0.17 mL||0.34 mL|
The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.
References are publications that support the products' biological activity.
Griffett et al (2013) A liver-selective LXR inverse agonist that suppresses hepatic steatosis. ACS Chem.Biol. 8 559 PMID: 23237488
If you know of a relevant reference for SR 9238, please let us know.
View Related Products by Target
View Related Products by Product Action
Keywords: SR 9238, supplier, SR9238, potent, selective, LXR, inverse, agonist, liver, obesity, receptors, LXR-like, Receptors, LXR-like, Receptors, Tocris Bioscience
Citations for SR 9238
Citations are publications that use Tocris products.
Currently there are no citations for SR 9238. Do you know of a great paper that uses SR 9238 from Tocris? If so please let us know.